Cancer has been one of the major crisis in the world. Medical researchers, as well as professionals, have been conducting extensive research on the prevention, the treatment as well as the causes of cancer for an extended period now. Medical experts have made their studies available to the world on different social media platforms.
Mikhail Blagosklonny is one of the medical researchers who has been involved in cancer study and research. Mr. Mikhail is a scientist who majored in cancer and aging. He is a professor of oncology and works at Roswell Park Cancer Institute in New York. Blagosklonny studied internal medicine, cardiology, and experimental medicine and earned his M.D and Ph.D. from the First Pavlov State Medical University of St. Peterburg. Mikhail is very passionate about medicine, and for the time he has been practicing, he has gained vast experience. His experience led him to be elected as the Professor of Medicine at New York Medical College in 2002.
Mikhail Blagosklonny has also held other top positions in medical and research institutes including; Ordway Research Institute as a senior scientist a position he held until 2009 and was elected as a professor at Roswell Park Cancer Institute. The medical professor has been majoring his researches on cancer and targeted cancer therapies that protect a normal cell from damage, and the fundamental mechanism on aging, as well as anti-aging drugs.
Mikhail Blagosklonny is also a medical author who has written more than 300 medical papers. Over the years his researches have been revolving around tumor suppressor, oncogenes, molecular biology, as well as signal transduction. His unique style of approach on the study and his research has made him one of the top most researchers on cancer and aging therapeutics. TOR signal in aging is one of his famous papers. According to his study, Blagosklonny mentions that the over the development of cells is the primary cause of cancer, and aging and that aging is one of the causes of cancer.
Professor Mikhail is an editor at Impact journals, oncoscience and oncotarget. Oncotarget is a medical journal on oncology that is published weekly. Oncotarget is considered to be one of the most important journals that write on cancer.
View Mikhail’s profile on Loop.